ALXYD Financials
Newest figures come from the 10-K for Q3 FY2026, filed Jan 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALXYD SEC filings page.
ALXYD (ALXYD) reported $51K in revenue over the twelve months to Nov 30, 2025, up 92.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
ALXYD's business is dominated by expanding overhead, external financing, and a balance sheet with a sharply thinning equity cushion.
Revenue expanded from$21.5K in FY2024 to$37.8K in FY2025, yet the added revenue did not make the operating model more self-funding. SG&A reached$60.4K in FY2025, exceeding reported revenue and helping explain the-60.0% net margin.
Operating cash flow swung from
FY2025 liabilities were
Financial Health Signals
ALXYD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
ALXYD passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
ALXYD reported a net loss of $23K while generating $24K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
ALXYD generated $1K in revenue in Q3 2026. This represents a decrease of 87.6% from the same quarter a year earlier. Against the prior quarter it is down 95.5%.
ALXYD reported -$3K in net income in Q3 2026. This represents a decrease of 729.0% from the same quarter a year earlier. Against the prior quarter it is down 129.0%.
Not reported for Q3 2026.
Cash & Balance Sheet
ALXYD held $0 in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
ALXYD's gross margin was 100.0% in Q3 2026, indicating the percentage of revenue retained after direct costs. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
ALXYD's ROE was -2.6% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.3 percentage points.
Not reported for Q3 2026.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for Q3 2026.
ALXYD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-K | Q2'2610-K | Q1'26 | Q4'2510-K | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1K-87.6% | $24K+130.5% | $11K+188.9% | $14K+335.4% | $9K+168.5% | $11K+51.6% | $4K-49.9% | $3K |
| Cost of Revenue | $0 | $0 | $11K+188.9% | $34K+926.4% | $0-100.0% | $0-100.0% | $4K-49.9% | $3K |
| Gross Profit | $1K-87.6% | $24K+130.5% | $11K+188.9% | -$19K-690.9% | $9K+168.5% | $11K+51.6% | $4K-49.9% | $3K |
| SG&A Expenses | $4K-58.3% | $16K-21.3% | $43K+164.1% | $15K+377.5% | $9K+141.1% | $20K+85.4% | $16K+68.2% | $3K |
| Income Tax | $0 | $0 | N/A | N/A | $0 | $0+100.0% | N/A | N/A |
| Net Income | -$3K-729.0% | $9K+191.6% | -$32K-156.1% | -$587+16.1% | -$303+39.4% | -$9K-147.4% | -$12K-603.9% | -$700 |
| EPS (Basic) | $0.00 | $0.00 | N/A | N/A | $0.00 | $0.00-100.0% | N/A | N/A |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A |
| Diluted Shares (Avg) | 18M+168.3% | 7M | 7M | N/A | 7M+33.8% | 7M+33.9% | 7M+33.9% | N/A |
Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA, Interest Expense.
ALXYD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-K | Q2'2610-K | Q1'26 | Q4'2510-K | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $98K+2.7% | $102K+1.8% | $117K+44.2% | $116K+7.8% | $95K+132.9% | $100K+145.5% | $81K | $108K+119.9% |
| Current Assets | $4K-88.7% | $6K-84.6% | $20K-40.9% | $41K-51.3% | $33K+2385.9% | $37K+10903.9% | $33K | $85K+484.9% |
| Cash & Equivalents | $0-100.0% | $0-100.0% | $17K+8585.9% | $14K+52.8% | $1K-7.5% | $33-90.1% | $192-59.3% | $9K+20.8% |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $15K |
| Total Liabilities | $622-99.3% | $2K-98.2% | $144K+118.5% | $111K+38.8% | $89K+96.1% | $94K+106.5% | $66K | $80K+65.9% |
| Current Liabilities | $622-99.3% | $2K-98.2% | $144K+118.5% | $111K+38.8% | $89K+96.1% | $94K+106.5% | $66K | $80K+65.9% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | $97K+1527.2% | $100K+1488.7% | -$26K-265.9% | $5K-80.8% | $6K+229.0% | $6K+235.5% | $16K+2020.2% | $28K+2920.2% |
| Retained Earnings | -$59K-78.9% | -$56K-72.8% | -$65K-180.8% | -$34K-209.0% | -$33K-224.5% | -$33K-438.2% | -$23K | -$11K-166.3% |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Long-Term Debt.
ALXYD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-K | Q2'2610-K | Q1'26 | Q4'2510-K | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$622+95.8% | -$55K-447.2% | $21K+600.4% | $27K+162.4% | -$15K+23.4% | $16K+11389.3% | -$4K-2084.7% | -$43K-278.1% |
| Investing Cash Flow | $0 | $0+100.0% | -$24K+5.5% | -$14K-182.4% | $0 | -$16K | -$25K-262.9% | $17K |
| Financing Cash Flow | $622-96.1% | $38K+106025.0% | $6K-70.2% | $0-100.0% | $16K-21.3% | $36 | $21K+13665.3% | $33K |
| Dividends Paid | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.
ALXYD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-K | Q2'2610-K | Q1'26 | Q4'2510-K | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | -135.7% | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 100.0% |
| Net Margin | -228.4% | 35.4%+124.6pp | -274.7% | -4.1%+17.2pp | -3.4%+11.8pp | -89.1%-34.5pp | -310.0% | -21.3% |
| Return on Equity | -2.6%+2.5pp | 8.7%+159.0pp | N/A | -10.9%-8.4pp | -5.1% | -150.3% | -78.2% | -2.5% |
| Return on Assets | -2.6%-2.2pp | 8.5%+18.0pp | -26.8%-11.7pp | -0.5%+0.1pp | -0.3%+0.9pp | -9.5%-0.1pp | -15.1% | -0.7% |
| Current Ratio | 6.03+5.7x | 3.27+2.9x | 0.14-0.4x | 0.37-0.7x | 0.37+0.3x | 0.39+0.4x | 0.51 | 1.06+0.8x |
| Debt-to-Equity | 0.01-14.9x | 0.02-14.9x | N/A | 20.57+17.7x | 14.95 | 14.88 | 4.17 | 2.85-49.0x |
| Asset Turnover | 0.01-0.1x | 0.24+0.1x | 0.100.0x | 0.12+0.1x | 0.090.0x | 0.11-0.1x | 0.05 | 0.03 |
Not reported in any period shown, so not listed: Operating Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Net Margin.
Note: The current ratio is below 1.0 (0.37), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where ALXYD Ranks
Frequently Asked Questions
What is ALXYD's annual revenue?
ALXYD (ALXYD) reported $38K in total revenue for fiscal year 2025. This represents a 75.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ALXYD's revenue growing?
ALXYD (ALXYD) revenue grew by 75.5% year-over-year, from $22K to $38K in fiscal year 2025.
Is ALXYD profitable?
No, ALXYD (ALXYD) reported a net income of -$23K in fiscal year 2025, with a net profit margin of -60.0%.
What is ALXYD's gross margin?
ALXYD (ALXYD) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is ALXYD's net profit margin?
ALXYD (ALXYD) had a net profit margin of -60.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ALXYD's return on equity (ROE)?
ALXYD (ALXYD) has a return on equity of -419.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ALXYD's operating cash flow?
ALXYD (ALXYD) generated $24K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ALXYD's total assets?
ALXYD (ALXYD) had $116K in total assets as of fiscal year 2025, including both current and long-term assets.
What is ALXYD's current ratio?
ALXYD (ALXYD) had a current ratio of 0.37 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is ALXYD's debt-to-equity ratio?
ALXYD (ALXYD) had a debt-to-equity ratio of 20.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ALXYD's return on assets (ROA)?
ALXYD (ALXYD) had a return on assets of -19.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ALXYD's Piotroski F-Score?
ALXYD (ALXYD) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ALXYD's earnings high quality?
ALXYD (ALXYD) reported a net loss of $23K while generating $24K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.